Global Throat Pastilles and Cough Drops Market 2024-2028

The throat pastilles and cough drops market is forecasted to grow by USD 1.25 bn during 2023-2028, accelerating at a CAGR of 3.72% during the forecast period. The report on the throat pastilles and cough drops market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by advantages over other dosage forms, increasing incidences of respiratory tract infections, and expanding geriatric population base driving the market for throat pastilles and cough drops.

Market Scope
Base Year	2023
End Year	2028
Series Year	2024-2028
Growth Momentum	Accelerate
YOY 2024	3.28%
CAGR	3.72%
Incremental Value	$1.25bn

Technavio's throat pastilles and cough drops market is segmented as below:

By Type

Hard tablet lozenges
Soft tablet lozenges
Compressed tablet lozenges

By End-user

Hospitals
Clinics
Others

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the emergence of innovative throat pastilles and cough drops lozenges as one of the prime reasons driving the throat pastilles and cough drops market growth during the next few years. Also, advancements in packaging techniques and growing focus of vendors toward enhancing distribution network will lead to sizable demand in the market.

The report on the throat pastilles and cough drops market covers the following areas:

Throat pastilles and cough drops market sizing
Throat pastilles and cough drops market forecast
Throat pastilles and cough drops market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading throat pastilles and cough drops market vendors that include Andre Prost Inc, Aurobindo Pharma Ltd., Boyd Pharmaceuticals, CVS Health Corp., FISHERMANSFRIEND.COM, GRETHERS USA, iNova Pharmaceuticals, Johnson and Johnson, Lanes Health, Maneesh Pharmaceuticals Ltd, Mondelez International Inc., PINE BROS LLC., Prestige Consumer Healthcare Inc., Prince Care Pharma Pvt Ltd, Procter and Gamble, Quantum Health, Reckitt Benckiser Group Plc, Ricola Group AG, STADA Arzneimittel AG, and Walgreens Boots Alliance Inc.. Also, the throat pastilles and cough drops market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Product Code: IRTNTR40260

1 Executive Summary

1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
Exhibit 06: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

4.1 Global throat pastilles and cough drops market 2018 - 2022
Exhibit 18: Historic Market Size - Data Table on global throat pastilles and cough drops market 2018 - 2022 ($ billion)
4.2 Type Segment Analysis 2018 - 2022
Exhibit 19: Historic Market Size - Type Segment 2018 - 2022 ($ billion)
4.3 End-user Segment Analysis 2018 - 2022
Exhibit 20: Historic Market Size - End-user Segment 2018 - 2022 ($ billion)
4.4 Geography Segment Analysis 2018 - 2022
Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
4.5 Country Segment Analysis 2018 - 2022
Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)

5 Five Forces Analysis

5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Type

6.1 Market segments
Exhibit 30: Chart on Type - Market share 2023-2028 (%)
Exhibit 31: Data Table on Type - Market share 2023-2028 (%)
6.2 Comparison by Type
Exhibit 32: Chart on Comparison by Type
Exhibit 33: Data Table on Comparison by Type
6.3 Hard tablet lozenges - Market size and forecast 2023-2028
Exhibit 34: Chart on Hard tablet lozenges - Market size and forecast 2023-2028 ($ billion)
Exhibit 35: Data Table on Hard tablet lozenges - Market size and forecast 2023-2028 ($ billion)
Exhibit 36: Chart on Hard tablet lozenges - Year-over-year growth 2023-2028 (%)
Exhibit 37: Data Table on Hard tablet lozenges - Year-over-year growth 2023-2028 (%)
6.4 Soft tablet lozenges - Market size and forecast 2023-2028
Exhibit 38: Chart on Soft tablet lozenges - Market size and forecast 2023-2028 ($ billion)
Exhibit 39: Data Table on Soft tablet lozenges - Market size and forecast 2023-2028 ($ billion)
Exhibit 40: Chart on Soft tablet lozenges - Year-over-year growth 2023-2028 (%)
Exhibit 41: Data Table on Soft tablet lozenges - Year-over-year growth 2023-2028 (%)
6.5 Compressed tablet lozenges - Market size and forecast 2023-2028
Exhibit 42: Chart on Compressed tablet lozenges - Market size and forecast 2023-2028 ($ billion)
Exhibit 43: Data Table on Compressed tablet lozenges - Market size and forecast 2023-2028 ($ billion)
Exhibit 44: Chart on Compressed tablet lozenges - Year-over-year growth 2023-2028 (%)
Exhibit 45: Data Table on Compressed tablet lozenges - Year-over-year growth 2023-2028 (%)
6.6 Market opportunity by Type
Exhibit 46: Market opportunity by Type ($ billion)
Exhibit 47: Data Table on Market opportunity by Type ($ billion)

7 Market Segmentation by End-user

7.1 Market segments
Exhibit 48: Chart on End-user - Market share 2023-2028 (%)
Exhibit 49: Data Table on End-user - Market share 2023-2028 (%)
7.2 Comparison by End-user
Exhibit 50: Chart on Comparison by End-user
Exhibit 51: Data Table on Comparison by End-user
7.3 Hospitals - Market size and forecast 2023-2028
Exhibit 52: Chart on Hospitals - Market size and forecast 2023-2028 ($ billion)
Exhibit 53: Data Table on Hospitals - Market size and forecast 2023-2028 ($ billion)
Exhibit 54: Chart on Hospitals - Year-over-year growth 2023-2028 (%)
Exhibit 55: Data Table on Hospitals - Year-over-year growth 2023-2028 (%)
7.4 Clinics - Market size and forecast 2023-2028
Exhibit 56: Chart on Clinics - Market size and forecast 2023-2028 ($ billion)
Exhibit 57: Data Table on Clinics - Market size and forecast 2023-2028 ($ billion)
Exhibit 58: Chart on Clinics - Year-over-year growth 2023-2028 (%)
Exhibit 59: Data Table on Clinics - Year-over-year growth 2023-2028 (%)
7.5 Others - Market size and forecast 2023-2028
Exhibit 60: Chart on Others - Market size and forecast 2023-2028 ($ billion)
Exhibit 61: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
Exhibit 62: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibit 63: Data Table on Others - Year-over-year growth 2023-2028 (%)
7.6 Market opportunity by End-user
Exhibit 64: Market opportunity by End-user ($ billion)
Exhibit 65: Data Table on Market opportunity by End-user ($ billion)

8 Customer Landscape

8.1 Customer landscape overview
Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
Exhibit 67: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibit 68: Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Exhibit 69: Chart on Geographic comparison
Exhibit 70: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Exhibit 71: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibit 72: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibit 73: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibit 74: Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Exhibit 75: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibit 76: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibit 77: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 78: Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Exhibit 79: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibit 80: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibit 81: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibit 82: Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Exhibit 87: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibit 88: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibit 89: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibit 90: Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 Germany - Market size and forecast 2023-2028
Exhibit 91: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibit 92: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibit 93: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibit 94: Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.9 Japan - Market size and forecast 2023-2028
Exhibit 95: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibit 96: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibit 97: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibit 98: Data Table on Japan - Year-over-year growth 2023-2028 (%)
9.10 UK - Market size and forecast 2023-2028
Exhibit 99: Chart on UK - Market size and forecast 2023-2028 ($ billion)
Exhibit 100: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Exhibit 101: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibit 102: Data Table on UK - Year-over-year growth 2023-2028 (%)
9.11 Canada - Market size and forecast 2023-2028
Exhibit 103: Chart on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibit 104: Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibit 105: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibit 106: Data Table on Canada - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 107: Market opportunity By Geographical Landscape ($ billion)
Exhibit 108: Data Tables on Market opportunity By Geographical Landscape ($ billion)

10 Drivers, Challenges, and Trends

10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 109: Impact of drivers and challenges in 2023 and 2028
10.4 Market trends

11 Vendor Landscape

11.1 Overview
11.2 Vendor landscape
Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 111: Overview on factors of disruption
11.4 Industry risks
Exhibit 112: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
Exhibit 113: Vendors covered
12.2 Market positioning of vendors
Exhibit 114: Matrix on vendor position and classification
12.3 Andre Prost Inc
Exhibit 115: Andre Prost Inc - Overview
Exhibit 116: Andre Prost Inc - Product / Service
Exhibit 117: Andre Prost Inc - Key offerings
12.4 Aurobindo Pharma Ltd.
Exhibit 118: Aurobindo Pharma Ltd. - Overview
Exhibit 119: Aurobindo Pharma Ltd. - Product / Service
Exhibit 120: Aurobindo Pharma Ltd. - Key offerings
12.5 Boyd Pharmaceuticals
Exhibit 121: Boyd Pharmaceuticals - Overview
Exhibit 122: Boyd Pharmaceuticals - Product / Service
Exhibit 123: Boyd Pharmaceuticals - Key offerings
12.6 CVS Health Corp.
Exhibit 124: CVS Health Corp. - Overview
Exhibit 125: CVS Health Corp. - Business segments
Exhibit 126: CVS Health Corp. - Key offerings
Exhibit 127: CVS Health Corp. - Segment focus
12.7 FISHERMANSFRIEND.COM
Exhibit 128: FISHERMANSFRIEND.COM - Overview
Exhibit 129: FISHERMANSFRIEND.COM - Product / Service
Exhibit 130: FISHERMANSFRIEND.COM - Key offerings
12.8 GRETHERS USA
Exhibit 131: GRETHERS USA - Overview
Exhibit 132: GRETHERS USA - Product / Service
Exhibit 133: GRETHERS USA - Key offerings
12.9 iNova Pharmaceuticals
Exhibit 134: iNova Pharmaceuticals - Overview
Exhibit 135: iNova Pharmaceuticals - Product / Service
Exhibit 136: iNova Pharmaceuticals - Key offerings
12.10 Johnson and Johnson
Exhibit 137: Johnson and Johnson - Overview
Exhibit 138: Johnson and Johnson - Business segments
Exhibit 139: Johnson and Johnson - Key news
Exhibit 140: Johnson and Johnson - Key offerings
Exhibit 141: Johnson and Johnson - Segment focus
12.11 Lanes Health
Exhibit 142: Lanes Health - Overview
Exhibit 143: Lanes Health - Product / Service
Exhibit 144: Lanes Health - Key offerings
12.12 Mondelez International Inc.
Exhibit 145: Mondelez International Inc. - Overview
Exhibit 146: Mondelez International Inc. - Business segments
Exhibit 147: Mondelez International Inc. - Key news
Exhibit 148: Mondelez International Inc. - Key offerings
Exhibit 149: Mondelez International Inc. - Segment focus
12.13 PINE BROS LLC.
Exhibit 150: PINE BROS LLC. - Overview
Exhibit 151: PINE BROS LLC. - Product / Service
Exhibit 152: PINE BROS LLC. - Key offerings
12.14 Prestige Consumer Healthcare Inc.
Exhibit 153: Prestige Consumer Healthcare Inc. - Overview
Exhibit 154: Prestige Consumer Healthcare Inc. - Business segments
Exhibit 155: Prestige Consumer Healthcare Inc. - Key offerings
Exhibit 156: Prestige Consumer Healthcare Inc. - Segment focus
12.15 Procter and Gamble
Exhibit 157: Procter and Gamble - Overview
Exhibit 158: Procter and Gamble - Business segments
Exhibit 159: Procter and Gamble - Key offerings
Exhibit 160: Procter and Gamble - Segment focus
12.16 Reckitt Benckiser Group Plc
Exhibit 161: Reckitt Benckiser Group Plc - Overview
Exhibit 162: Reckitt Benckiser Group Plc - Business segments
Exhibit 163: Reckitt Benckiser Group Plc - Key offerings
Exhibit 164: Reckitt Benckiser Group Plc - Segment focus
12.17 Ricola Group AG
Exhibit 165: Ricola Group AG - Overview
Exhibit 166: Ricola Group AG - Product / Service
Exhibit 167: Ricola Group AG - Key offerings

13 Appendix

13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 168: Inclusions checklist
Exhibit 169: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 170: Currency conversion rates for US$
13.4 Research methodology
Exhibit 171: Research methodology
Exhibit 172: Validation techniques employed for market sizing
Exhibit 173: Information sources
13.5 List of abbreviations
Exhibit 174: List of abbreviations